Company intelligence / Profile preview

VCP Pharmaceutical Joint Stock Company

Hanoi, Vietnam

Ownership: Private
Employees: ~65
Development stage: Other

Overview

VCP Pharmaceutical is Sinopharm's first overseas pharmaceutical joint venture, operating as Vietnam's first WHO-GMP-certified factory producing antibiotic powder injections. The company has achieved 95% pharmacy coverage nationwide with a 25% market share, and its traditional Chinese medicine business experienced 150% revenue growth in 2022 and 70% growth in 2023.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Sinopharm

Beyond the preview

Go deeper on VCP Pharmaceutical Joint Stock Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VCP Pharmaceutical Joint Stock Company.

Explore the full profile